“Antiretroviral HIV Medication (32596142246)” by NIAID is licensed under CC BY 2.0.
As of March 2026, thousands are at risk as the Florida Department of Health has continued to move forward with Governor Ron DeSantis’s plans to defund HIV treatment.
–
By Genesis Muckle
TAMPA, Fla. — On Tuesday, March 24, Judge Jonathan Sjostrom ruled in favor of Gov. Ron DeSantis moving forward with the reduction of treatment for people with HIV/AIDS, including the daily pill Biktarvy. This decision follows a prolonged dispute over how the government manages the funds for programs that aim to make healthcare more accessible to everyone.
The program affected the most by this change is the AIDS Drug Assistance Program (ADAP). ADAP is a program that has helped low-income individuals access the HIV medication they need. With nearly 16,000 people enrolled, many have depended on this program to maintain their treatment and help prevent the virus from spreading.
In January, the Florida Department of Health introduced the new policy to reduce funding for HIV/AIDS medication. Lawmakers were blindsided by this and raised concerns about the rule and its potential consequences for public safety.
On Feb. 24, the Department moved forward with the rule and solidified the defunding of HIV/AIDS treatments. After facing legal pressure, on Feb. 11, just weeks before this, the state announced that it would be moving forward with the formal rulemaking process.
The legal pressure came from the AIDS Healthcare Foundation (AHF) after the foundation filed a lawsuit against the state. AHF argued that the officials failed to follow the required procedures, including failing to allow a 21-day waiting period before moving forward with these changes.
After a hearing was granted, the case was paused when the state agreed to move forward with the formal rulemaking process, ultimately placing a stay on the case.
Despite this legal setback, HIV/AIDS medication advocates have warned of the consequences of cutting the funds for medication, including a high risk of transmission and long-term health complications for individuals with HIV.
Public health experts have also raised concerns about community impact, noting that limiting access to this treatment could undermine the efforts that healthcare professionals have made to control HIV transmission across states.
In response to the funding cuts, some lawmakers in both the Florida House and Senate began working on restoring funding to the program. While these efforts signaled concerns at the legislative level, it is still not clear how quickly they can help those affected.
As of March of this year, the state approved a short-term funding of $31 million for HIV medication. This is after the Florida Department of Health made eligibility harder for more than 12,000 individuals with HIV, keeping them from the medication that could save their lives.
The Florida House of Representatives has approved funding for the program through June, allowing low-income residents three months to access the medication that they need.
For communities like these, according to the Tampa Bay Times, where access to healthcare resources can be uneven, the potential loss of medication assistance raises concerns about equity and public health. This can cause local clinics and advocacy organizations to be forced to prepare for the impact of stretching already limited resources to help support patients in need.
In the coming months, the program’s future may depend on ongoing legal challenges and legislative action. Until then, patients and advocates are watching closely, knowing that the outcome will have life-altering consequences for the communities across Florida.